Related Experiment Video

Updated: Mar 27, 2026

Transplantation Into the Mouse Ovarian Fat Pad
09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

12.1K

PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer

Weiwei Zhang1, Rong Liu2, Chunhui Tang1

  • 1Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, People's Republic of China.

International Journal of Biological Macromolecules
|January 17, 2016
PubMed

Insights

Cyclin-Dependent Kinase 14 (PFTK1) is overexpressed in epithelial ovarian cancer (EOC), promoting tumor growth and progression. Inhibiting PFTK1 significantly reduced cancer cell proliferation, migration, and invasion, suggesting its role as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Cyclin-Dependent Kinase 14 (PFTK1) is a serine/threonine-protein kinase involved in cell cycle regulation.
  • Its role in epithelial ovarian cancer (EOC) development requires further investigation.

Purpose of the Study:

  • To investigate the role of PFTK1 in the development and progression of epithelial ovarian cancer (EOC).

Main Methods:

  • Western blot and immunohistochemistry were used to detect PFTK1 expression in EOC tissues and cells.
  • Statistical analysis correlated PFTK1 expression with clinicopathological factors.
  • In vitro studies utilized serum starvation and re-feeding models.
  • Small interfering RNA (siRNA) was used to knock down PFTK1 expression.

Main Results:

  • PFTK1 was significantly overexpressed in EOC tissues and cells compared to normal controls.
  • High PFTK1 expression correlated with advanced tumor grade, FIGO stage, lymph node metastasis, and Ki-67 expression.
  • PFTK1 expression levels fluctuated with serum availability, increasing upon re-feeding.
  • siRNA-mediated knockdown of PFTK1 suppressed ovarian cancer cell proliferation, migration, and invasion.

Conclusions:

  • PFTK1 is upregulated in epithelial ovarian cancer and is associated with poor prognosis.
  • PFTK1 plays a critical role in promoting ovarian cancer cell proliferation, migration, and invasion.
  • PFTK1 represents a potential therapeutic target for epithelial ovarian cancer.
Keywords:
Epithelial ovarian cancerOverexpressionPFTK1

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K
Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

3.3K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K